Sign in
4

Changes in Ownership

ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001209191-22-001331

Director sold 4,500 shares at an average $64.72 ($291,244)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Waddill William D. Director 2022-01-03 Sale −2,100 $64.23 $134,883 28,150 D: show line 1 in the form
Waddill William D. Director 2022-01-03 Sale −2,128 $65.01 $138,341 26,022 D: show line 2 in the form
Waddill William D. Director 2022-01-03 Sale −272 $66.25 $18,020 25,750 D: show line 3 in the form
Open-market sales · 4,500 sh · avg $64.72 · $291,244
Loading xslF345X03/doc4.xml…